Technical Analysis for INSM - Insmed, Inc.

Grade Last Price % Change Price Change
grade C 28.07 -3.67% -1.07
INSM closed down 3.67 percent on Monday, May 20, 2019, on 59 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical INSM trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -3.67%
20 DMA Resistance Bearish -4.30%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.30%
NR7 Range Contraction -4.30%
NR7-2 Range Contraction -4.30%
Up 3 Days in a Row Strength -4.30%
Calm After Storm Range Contraction -3.17%
NR7 Range Contraction -3.17%
NR7-2 Range Contraction -3.17%
Calm After Storm Range Contraction -1.72%

Older signals for INSM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing targeted inhalation therapies for patients battling serious lung diseases. Its lead candidate ARIKACE is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the treatment for two identified patient populations comprising cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). The company's Phase III registrational study of ARIKACE in CF patients in Europe and Canada has completed enrollment; and Phase II clinical trial in NTM patients is under way with clinical results. Insmed Incorporated was founded in 1999 and is headquartered in Monmouth Junction, New Jersey.
Biopharmaceutical Medical Specialties Infectious Diseases Cystic Fibrosis Infectious Causes Of Cancer Microbiology Bacterial Diseases Bacteriology Pseudomonas Tuberculosis Nontuberculous Mycobacteria
Is INSM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 33.13
52 Week Low 11.31
Average Volume 665,304
200-Day Moving Average 22.5817
50-Day Moving Average 29.8686
20-Day Moving Average 29.676
10-Day Moving Average 28.553
Average True Range 1.4362
ADX 12.38
+DI 21.2252
-DI 23.8623
Chandelier Exit (Long, 3 ATRs ) 27.9214
Chandelier Exit (Short, 3 ATRs ) 31.4386
Upper Bollinger Band 32.3228
Lower Bollinger Band 27.0292
Percent B (%b) 0.2
BandWidth 17.837984
MACD Line -0.4282
MACD Signal Line -0.2793
MACD Histogram -0.1489
Fundamentals Value
Market Cap 1.75 Billion
Num Shares 62.4 Million
EPS -3.04
Price-to-Earnings (P/E) Ratio -9.23
Price-to-Sales 0.00
Price-to-Book 20.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.80
Resistance 3 (R3) 29.99 29.60 29.51
Resistance 2 (R2) 29.60 29.16 29.51 29.41
Resistance 1 (R1) 28.84 28.89 28.65 28.65 29.32
Pivot Point 28.45 28.45 28.36 28.36 28.45
Support 1 (S1) 27.69 28.01 27.50 27.50 26.82
Support 2 (S2) 27.30 27.74 27.21 26.73
Support 3 (S3) 26.54 27.30 26.63
Support 4 (S4) 26.35